- Stocks
- Healthcare
- NASDAQ: CELU

Price (delayed)

$2.92

Market cap

$56.58M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$10.1

Enterprise value

$102.56M

CELU's debt is down by 9% year-on-year

The gross margin has dropped by 180% year-on-year but it has increased by 8% since the previous quarter

The gross profit has dropped by 163% year-on-year but it is up by 10% since the previous quarter

The company's net income has shrunk by 119% QoQ

Celularity's EPS has shrunk by 110% QoQ

What are the main financial stats of CELU

Market
Valuations
Earnings

Shares outstanding

19.38M

Market cap

$56.58M

Enterprise value

$102.56M

Price to earnings (P/E)

N/A

Price to book (P/B)

1.84

Price to sales (P/S)

3.72

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.94

Revenue

$14.79M

EBIT

-$179.04M

EBITDA

-$169.66M

Free cash flow

-$65.18M

Per share
Balance sheet
Liquidity

EPS

-$10.1

Free cash flow per share

-$3.46

Book value per share

$1.58

Revenue per share

$0.79

TBVPS

$7.34

Total assets

$157.19M

Total liabilities

$126.95M

Debt

$61.08M

Equity

$30.25M

Working capital

-$68.13M

Debt to equity

2.02

Current ratio

0.19

Quick ratio

0.25

Net debt/EBITDA

-0.27

Margins
Efficiency
Dividend

EBITDA margin

-1,147.3%

Gross margin

-25%

Net margin

-1,226.7%

Operating margin

-2,334.9%

Return on assets

-62.2%

Return on equity

-144.2%

Return on invested capital

-148%

Return on capital employed

-246.8%

Return on sales

-1,210.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Celularity stock price performed over time

Intraday

-3.31%

1 week

-8.46%

1 month

-4.26%

1 year

418.65%

YTD

18.03%

QTD

-6.71%

How have Celularity's revenue and profit performed over time

Revenue

$14.79M

Gross profit

-$3.7M

Operating income

-$345.29M

Net income

-$181.41M

Gross margin

-25%

Net margin

-1,226.7%

Celularity's operating margin has shrunk by 182% YoY and by 24% QoQ

The gross margin has dropped by 180% year-on-year but it has increased by 8% since the previous quarter

The gross profit has dropped by 163% year-on-year but it is up by 10% since the previous quarter

CELU's net margin has dropped by 124% since the previous quarter

What is Celularity's growth rate over time

What is Celularity stock price valuation

P/E

N/A

P/B

1.84

P/S

3.72

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.94

Celularity's EPS has shrunk by 110% QoQ

The P/B is 84% more than the last 4 quarters average of 1.0

CELU's equity has dropped by 82% year-on-year and by 74% since the previous quarter

CELU's P/S is 76% below its 5-year quarterly average of 15.6 and 41% below its last 4 quarters average of 6.3

CELU's revenue is down by 21% year-on-year and by 2.3% since the previous quarter

How efficient is Celularity business performance

The return on equity has dropped by 178% since the previous quarter

CELU's ROA has dropped by 172% since the previous quarter

CELU's return on invested capital has dropped by 135% since the previous quarter

Celularity's return on sales has shrunk by 125% QoQ

What is CELU's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CELU.

How did Celularity financials performed over time

CELU's total assets is 24% greater than its total liabilities

Celularity's current ratio has shrunk by 79% YoY and by 32% QoQ

The quick ratio has dropped by 74% year-on-year and by 29% since the previous quarter

CELU's debt is 102% greater than its equity

CELU's equity has dropped by 82% year-on-year and by 74% since the previous quarter

CELU's debt is down by 9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.